OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Precision treatment of pancreatic ductal adenocarcinoma
Hongyun Wei, He Ren
Cancer Letters (2024) Vol. 585, pp. 216636-216636
Closed Access | Times Cited: 8
Hongyun Wei, He Ren
Cancer Letters (2024) Vol. 585, pp. 216636-216636
Closed Access | Times Cited: 8
Showing 8 citing articles:
Transforming pancreaticobiliary cancer treatment: Exploring the frontiers of adoptive cell therapy and cancer vaccines
Nawal Amhis, Julie Carignan, Lee‐Hwa Tai
Deleted Journal (2024) Vol. 32, Iss. 3, pp. 200825-200825
Open Access | Times Cited: 4
Nawal Amhis, Julie Carignan, Lee‐Hwa Tai
Deleted Journal (2024) Vol. 32, Iss. 3, pp. 200825-200825
Open Access | Times Cited: 4
Secretory Trefoil Factor 1 (TFF1) promotes gemcitabine resistance through chemokine receptor CXCR4 in Pancreatic Ductal Adenocarcinoma
Ashu Shah, Rahat Jahan, Sophia G. Kisling, et al.
Cancer Letters (2024) Vol. 598, pp. 217097-217097
Closed Access | Times Cited: 4
Ashu Shah, Rahat Jahan, Sophia G. Kisling, et al.
Cancer Letters (2024) Vol. 598, pp. 217097-217097
Closed Access | Times Cited: 4
Tumor-derived miR-203a-3p potentiates muscle wasting by inducing muscle ferroptosis in pancreatic cancer
Yumeng Hu, Yifu Hu, Shaobo Zhang, et al.
Cancer Letters (2025) Vol. 614, pp. 217523-217523
Closed Access
Yumeng Hu, Yifu Hu, Shaobo Zhang, et al.
Cancer Letters (2025) Vol. 614, pp. 217523-217523
Closed Access
Chlorophyllin exerts synergistic anti-tumor effect with gemcitabine in pancreatic cancer by inducing cuproptosis
Jiaqiang Ren, Tong Su, Jiachun Ding, et al.
Molecular Medicine (2025) Vol. 31, Iss. 1
Open Access
Jiaqiang Ren, Tong Su, Jiachun Ding, et al.
Molecular Medicine (2025) Vol. 31, Iss. 1
Open Access
Gap-App: A Sex-Distinct AI-Based Predictor for Pancreatic Ductal Adenocarcinoma Survival as A Web Application Open to Patients and Physicians
Anuj Ojha, Shujun Zhao, Basil Akpunonu, et al.
Cancer Letters (2025), pp. 217689-217689
Open Access
Anuj Ojha, Shujun Zhao, Basil Akpunonu, et al.
Cancer Letters (2025), pp. 217689-217689
Open Access
Discovery of CMNPD31124 as a novel marine-derived PKMYT1 inhibitor for pancreatic ductal adenocarcinoma therapy: computational and biological insights
Chaojie Huang, Ting Wang, Rui Chen, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Chaojie Huang, Ting Wang, Rui Chen, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Gap-App: A sex-distinct AI-based predictor for pancreatic ductal adenocarcinoma survival as a web application open to patients and physicians
Anuj Ojha, Shujun Zhao, Jian‐Ting Zhang, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Anuj Ojha, Shujun Zhao, Jian‐Ting Zhang, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Sex-Related Differences in Pancreatic Ductal Adenocarcinoma Progression and Response to Therapy
Jelena Grahovac, Ana Djurić, Miljana Tanić, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 23, pp. 12669-12669
Open Access
Jelena Grahovac, Ana Djurić, Miljana Tanić, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 23, pp. 12669-12669
Open Access
The Use of Personalized Medicine in Pancreatic Ductal Adenocarcinoma (PDAC): New Therapeutic Opportunities
Inês Mendes, Nuno Vale
Future Pharmacology (2024) Vol. 4, Iss. 4, pp. 934-954
Open Access
Inês Mendes, Nuno Vale
Future Pharmacology (2024) Vol. 4, Iss. 4, pp. 934-954
Open Access
